MONTGOMERY, Ala. (AP) — Alabama has had no reports of adverse effects from a potentially contaminated medication prepared by a compounding pharmacy in Tennessee, officials from the Alabama Department of Public Health said Wednesday.
Only one clinic in Alabama received the injectable steroid product that is associated with the investigation, methylprednisolone acetate, Department official Kelley Stevens said. The drug was produced at Main Street Family Pharmacy in Newbern, Tenn. Health officials aren't saying where that Alabama clinic is located, but they say fewer than 100 patients received the steroid. All of them have been contacted and none has reported any symptoms.
Alabama was one of 13 states that received the drug. Alabama's health department began an investigation May 24 after the U.S. Food and Drug Administration reported problems with seven patients in two states.
The larger investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of the drug, also known as MPA. It's the same drug that was linked to last year's deadly outbreak of fungal meningitis.